MBNL1 and myotonic dystrophy type 1: MBNL inhibition in DM1 tissues leads to a shift from adult to fetal splicing events for MBNL-targeted RNAs and results in tissue-specific disease manifestations, including muscle hyperexcitability (myotonia) and insulin resistance.